Cell Therapy

Advancells offers innovative cell-based solutions for precision medicine.

Clinical Studies

We are actively engaged in clinical studies to advance regenerative medicine and improve treatment outcomes for patients with degenerative ailments.

Research Development

Our commitment to research and development drives the discovery of new therapeutic applications for adult stem cells, enhancing healthcare solutions globally.

CAR T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy is a type of immunotherapy for some types of blood cancer. It works by turning your T lymphocytes (T cells) into more efficient cancer-fighting machines. In CAR T-cell therapy, healthcare providers introduce a new gene into your T cells that changes your cells so they can do more to detect and kill cancerous cells. In some cases, CAR T-cell therapy can cure blood cancer. Other times, it helps people with certain blood cancers live longer.

Care at Cleveland Clinic

Chimeric antigen receptor (CAR) T-cell therapy treats some types of blood cancer. Scientists create the treatment by adding a lab-made gene to your cancer-fighting T cells. The change helps T cells detect and kill cancerous cells. Healthcare providers may use this treatment when other treatments aren’t effective or blood cancer comes back.

Autologous CAR T cell manufacturing.

The production of autologous CAR T cells begins with a patient’s leukapheresis, followed by T cell enrichment and activation. To promote the introduction and perhaps permanent integration of the CAR transgene, activated T cells are transduced (e.g., with a lentiviral vector). T cells that have been genetically engineered are then grown in either static or dynamic culture, cryopreserved, and reintroduced into the patient.

Contact Us

Get in touch for inquiries about our regenerative technologies and services.